102 related articles for article (PubMed ID: 10602481)
1. Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements.
Hajra KM; Ji X; Fearon ER
Oncogene; 1999 Dec; 18(51):7274-9. PubMed ID: 10602481
[TBL] [Abstract][Full Text] [Related]
2. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.
Graff JR; Herman JG; Lapidus RG; Chopra H; Xu R; Jarrard DF; Isaacs WB; Pitha PM; Davidson NE; Baylin SB
Cancer Res; 1995 Nov; 55(22):5195-9. PubMed ID: 7585573
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional defects underlie loss of E-cadherin expression in breast cancer.
Ji X; Woodard AS; Rimm DL; Fearon ER
Cell Growth Differ; 1997 Jul; 8(7):773-8. PubMed ID: 9218871
[TBL] [Abstract][Full Text] [Related]
4. Loss of expression and aberrant methylation of the CDH13 (H-cadherin) gene in breast and lung carcinomas.
Toyooka KO; Toyooka S; Virmani AK; Sathyanarayana UG; Euhus DM; Gilcrease M; Minna JD; Gazdar AF
Cancer Res; 2001 Jun; 61(11):4556-60. PubMed ID: 11389090
[TBL] [Abstract][Full Text] [Related]
5. Role of E boxes in the repression of E-cadherin expression.
Giroldi LA; Bringuier PP; de Weijert M; Jansen C; van Bokhoven A; Schalken JA
Biochem Biophys Res Commun; 1997 Dec; 241(2):453-8. PubMed ID: 9425291
[TBL] [Abstract][Full Text] [Related]
6. Mutant E-cadherin breast cancer cells do not display constitutive Wnt signaling.
van de Wetering M; Barker N; Harkes IC; van der Heyden M; Dijk NJ; Hollestelle A; Klijn JG; Clevers H; Schutte M
Cancer Res; 2001 Jan; 61(1):278-84. PubMed ID: 11196175
[TBL] [Abstract][Full Text] [Related]
7. Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo.
Hennig G; Behrens J; Truss M; Frisch S; Reichmann E; Birchmeier W
Oncogene; 1995 Aug; 11(3):475-84. PubMed ID: 7630631
[TBL] [Abstract][Full Text] [Related]
8. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of inactivation of E-cadherin in breast cancer cell lines.
Hiraguri S; Godfrey T; Nakamura H; Graff J; Collins C; Shayesteh L; Doggett N; Johnson K; Wheelock M; Herman J; Baylin S; Pinkel D; Gray J
Cancer Res; 1998 May; 58(9):1972-7. PubMed ID: 9581841
[TBL] [Abstract][Full Text] [Related]
11. Constitutive expression of the Id-1 promoter in human metastatic breast cancer cells is linked with the loss of NF-1/Rb/HDAC-1 transcription repressor complex.
Singh J; Murata K; Itahana Y; Desprez PY
Oncogene; 2002 Mar; 21(12):1812-22. PubMed ID: 11896613
[TBL] [Abstract][Full Text] [Related]
12. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression.
Mauro L; Catalano S; Bossi G; Pellegrino M; Barone I; Morales S; Giordano C; Bartella V; Casaburi I; Andò S
Cancer Res; 2007 Apr; 67(7):3412-21. PubMed ID: 17409452
[TBL] [Abstract][Full Text] [Related]
13. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element.
Rodrigo I; Cato AC; Cano A
Exp Cell Res; 1999 May; 248(2):358-71. PubMed ID: 10222128
[TBL] [Abstract][Full Text] [Related]
14. SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers.
Dallol A; Da Silva NF; Viacava P; Minna JD; Bieche I; Maher ER; Latif F
Cancer Res; 2002 Oct; 62(20):5874-80. PubMed ID: 12384551
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation regulates cadherin switching in squamous cell carcinoma.
Chen Q; Lipkina G; Song Q; Kramer RH
Biochem Biophys Res Commun; 2004 Mar; 315(4):850-6. PubMed ID: 14985090
[TBL] [Abstract][Full Text] [Related]
16. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
17. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
[TBL] [Abstract][Full Text] [Related]
18. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
19. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
20. Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines.
Yang SZ; Kohno N; Yokoyama A; Kondo K; Hamada H; Hiwada K
Int J Oncol; 2001 Mar; 18(3):541-8. PubMed ID: 11179484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]